Oncology - Medicine.net

Falling PSA levels found to predict longer survival in prostate cancer patients at high risk of metastases

byWolters Kluwer HealthTwelve-month landmark analysis of overall survival (OS) by prostate-specific antigen (PSA) decline subgroup for enzalutamide-treated men. Data cutoff: October 15, 2019. Cr

Updated on: January 02,2024

Falling PSA levels found to predict longer survival in prostate cancer patients at high risk of metastases

byWolters Kluwer HealthTwelve-month landmark analysis of overall survival (OS) by prostate-specific antigen (PSA) decline subgroup for enzalutamide-treated men. Data cutoff: October 15, 2019. Cr

Updated on:January 02,2024

Colorectal cancer initiation and progression: the role of low oxygen

byUniversity of LuxembourgScientists from the University of Luxembourg together with researchers from the Integrated Biobank of Luxembourg (IBBL) and the Luxembourg Institute of Health (LIH) hav

Updated on: December 22,2023

Colorectal cancer initiation and progression: the role of low oxygen

byUniversity of LuxembourgScientists from the University of Luxembourg together with researchers from the Integrated Biobank of Luxembourg (IBBL) and the Luxembourg Institute of Health (LIH) hav

Updated on:December 22,2023

New study categorizes and examines four different types of model related to cancerous tumors

by John Stevenson,City University LondonCategories of model and PubMed entries. Credit: Dr Constantino Carlos Reyes AldasoroThe term model is employed quite widely in science and technology.Rese

Updated on: January 07,2024

New study categorizes and examines four different types of model related to cancerous tumors

by John Stevenson,City University LondonCategories of model and PubMed entries. Credit: Dr Constantino Carlos Reyes AldasoroThe term model is employed quite widely in science and technology.Rese

Updated on:January 07,2024

Huge variations between countries in time for reimbursement decisions on new cancer drugs

byEuropean Society for Medical OncologySome European countries take more than twice as long as others to reach health technology assessment (HTA) decisions to reimburse new cancer drugs followin

Updated on: December 18,2023

Huge variations between countries in time for reimbursement decisions on new cancer drugs

byEuropean Society for Medical OncologySome European countries take more than twice as long as others to reach health technology assessment (HTA) decisions to reimburse new cancer drugs followin

Updated on:December 18,2023

Ketamine's promise for severe depression grows, but major questions remain

by University of MichiganCredit: CC0 Public DomainUsing an old anesthesia drug to pull people out of the depths of severe depression has gone from fringe idea to widespread use in just a few year

Updated on: May 26,2024

Ketamine's promise for severe depression grows, but major questions remain

by University of MichiganCredit: CC0 Public DomainUsing an old anesthesia drug to pull people out of the depths of severe depression has gone from fringe idea to widespread use in just a few year

Updated on:May 26,2024

Better surgical outcomes for colorectal cancer patients in hospitals with high case loads

byUniversity of WürzburgCredit: AI-generated imagePatients with colorectal cancer have a greater chance of survival if they are operated in hospitals with a high case load. This is because compl

Updated on: December 20,2023

Better surgical outcomes for colorectal cancer patients in hospitals with high case loads

byUniversity of WürzburgCredit: AI-generated imagePatients with colorectal cancer have a greater chance of survival if they are operated in hospitals with a high case load. This is because compl

Updated on:December 20,2023

Researchers clarify role of SMYD3 enzyme in prostate cancer progression

by Sarah Hansen,University of Maryland Baltimore CountySMYD3 loss impedes PCa progression.(A) Expression ofSMYD3mRNA from TCGA [GTEX normal (n= 105), TCGA tumor adjacent normal

Updated on: December 26,2023

Researchers clarify role of SMYD3 enzyme in prostate cancer progression

by Sarah Hansen,University of Maryland Baltimore CountySMYD3 loss impedes PCa progression.(A) Expression ofSMYD3mRNA from TCGA [GTEX normal (n= 105), TCGA tumor adjacent normal

Updated on:December 26,2023

Unique cancer drug discovered with help from Advanced Light Source begins historical clinical trial

by Aliyah Kovner,Lawrence Berkeley National LaboratoryA structural map of KRAS(G12C), showing the AMG 510 molecule in the binding pocket. Amgen is a Participating Research Team member of the Ber

Updated on: December 22,2023

Unique cancer drug discovered with help from Advanced Light Source begins historical clinical trial

by Aliyah Kovner,Lawrence Berkeley National LaboratoryA structural map of KRAS(G12C), showing the AMG 510 molecule in the binding pocket. Amgen is a Participating Research Team member of the Ber

Updated on:December 22,2023

Scientists uncover potential 'electrical language' of breast cancer cells

by Caroline Brogan,Imperial College LondonA wave of voltage fluctuations seen across the cells. Credit: Imperial College LondonNew research has found variable voltages in the membranes of breast

Updated on: December 27,2023

Scientists uncover potential 'electrical language' of breast cancer cells

by Caroline Brogan,Imperial College LondonA wave of voltage fluctuations seen across the cells. Credit: Imperial College LondonNew research has found variable voltages in the membranes of breast

Updated on:December 27,2023

Researchers shed light on cancer drug resistance, potential to expand use of PARP inhibitors across cancer types

byThe University of Hong KongInactivation of a DNA repair gene called FANCM enhances the formation of DNA damage and chromosomal instability induced by a PARP inhibitor, leading to massive cance

Updated on: August 27,2024

Researchers shed light on cancer drug resistance, potential to expand use of PARP inhibitors across cancer types

byThe University of Hong KongInactivation of a DNA repair gene called FANCM enhances the formation of DNA damage and chromosomal instability induced by a PARP inhibitor, leading to massive cance

Updated on:August 27,2024

Scientists identify a gene signature to assess cancer risk in people

byThe Wistar InstituteWistar's Dr. Maureen Murphy and lab. Credit: The Wistar InstituteIn a paper published inPNAS, Maureen Murphy, Ph.D., Deputy Director of Wistar's Ellen and Ron